Endocrinology Division, Department of Medicine, New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California, USA.
Eur J Endocrinol. 2020 Nov;183(5):R133-R147. doi: 10.1530/EJE-20-0665.
The SARS-CoV-2 virus responsible for the COVID-19 pandemic has generated an explosion of interest both in the mechanisms of infection leading to dissemination and expression of this disease, and in potential risk factors that may have a mechanistic basis for disease propagation or control. Vitamin D has emerged as a factor that may be involved in these two areas. The focus of this article is to apply our current understanding of vitamin D as a facilitator of immunocompetence both with regard to innate and adaptive immunity and to consider how this may relate to COVID-19 disease. There are also intriguing potential links to vitamin D as a factor in the cytokine storm that portends some of the most serious consequences of SARS-CoV-2 infection, such as the acute respiratory distress syndrome. Moreover, cardiac and coagulopathic features of COVID-19 disease deserve attention as they may also be related to vitamin D. Finally, we review the current clinical data associating vitamin D with SARS-CoV-2 infection, a putative clinical link that at this time must still be considered hypothetical.
导致 COVID-19 大流行的 SARS-CoV-2 病毒引起了人们极大的兴趣,不仅对导致这种疾病传播和表达的感染机制感兴趣,而且对可能具有疾病传播或控制机制基础的潜在危险因素也感兴趣。维生素 D 已成为一个可能涉及这两个领域的因素。本文的重点是应用我们目前对维生素 D 的理解,将其作为先天和适应性免疫的免疫能力促进剂,并考虑这与 COVID-19 疾病的关系。维生素 D 与预示 SARS-CoV-2 感染最严重后果(如急性呼吸窘迫综合征)的细胞因子风暴之间也存在有趣的潜在联系。此外,COVID-19 疾病的心脏和凝血功能障碍特征也值得关注,因为它们也可能与维生素 D 有关。最后,我们回顾了目前与 SARS-CoV-2 感染相关的维生素 D 的临床数据,这是一个目前仍被认为是假设的假设的临床联系。